Bryn Mawr Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $250K | Buy |
3,626
+12
| +0.3% | +$828 | 0.01% | 366 |
|
|
2025
Q1 | $251K | Sell |
3,614
-4,798
| -57% | -$333K | 0.02% | 341 |
|
|
2024
Q4 | $724K | Sell |
8,412
-66
| -0.8% | -$5.68K | 0.04% | 251 |
|
|
2024
Q3 | $1.01M | Sell |
8,478
-195
| -2% | -$23.2K | 0.05% | 224 |
|
|
2024
Q2 | $1.24M | Sell |
8,673
-305
| -3% | -$43.5K | 0.07% | 194 |
|
|
2024
Q1 | $1.15M | Sell |
8,978
-1,045
| -10% | -$134K | 0.07% | 210 |
|
|
2023
Q4 | $1.04M | Buy |
10,023
+2,672
| +36% | +$276K | 0.06% | 210 |
|
|
2023
Q3 | $669K | Buy |
+7,351
| New | +$669K | 0.04% | 249 |
|